This site is intended for Healthcare Professionals only.

Swiss competition watchdog probes Novartis over patent use

Date:

Share post:

The Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss drugmaker confirmed on Thursday, September 15.

COMCO conducted an early morning raid on the company on Sept. 13, it said in a statement that did not name Novartis, which subsequently said in its own statement that it was the group under investigation.

“The company allegedly attempted to protect its drug for the treatment of skin diseases against competing products by using one of its patents to initiate litigation proceedings,” COMCO said in a statement.

Novartis said COMCO had started an investigation in collaboration with the European Commission into the assertion of a patent in the broader field of dermatology treatments.

“In connection with this investigation, COMCO representatives visited the company headquarters in Basel,” it said.

“The opening of an investigation does not imply any finding of wrongdoing or any financial impact. Novartis is fully cooperating with the authorities and is confident to clarify the legitimacy of its position,” it added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Another wake-up call! Nuffield Trust report warns patients face ‘new normal’ of medicine shortages

Community Pharmacy England has already warned that medicine shortages and market instability are “at the worst that pharmacies...

NHS supply chain appoints Richard Evans as commercial executive director

Experienced leader to drive transformation in healthcare supply chain through new NHS  appointment NHS Supply Chain today announced the...

UK launches Critical Imports Council to secure supplies of medicines, smartphone chips

The Council aims to address the supply challenges businesses face and develop real-life solutions The UK government has...

Health secretary accuses NHS gender care influenced by ‘cultural values’

Wes Streeting challenges plans for improving mental health assessments amidst growing scrutiny over NHS gender care  In a...